Detalhe da pesquisa
1.
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 138(26): 2753-2767, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724563
2.
Computational flow cytometry as a diagnostic tool in suspected-myelodysplastic syndromes.
Cytometry A
; 99(8): 814-824, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942494
3.
TP53 mutations and relevance of expression of TP53 pathway genes in paediatric acute myeloid leukaemia.
Br J Haematol
; 188(5): 736-739, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31588562
4.
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting.
Br J Haematol
; 190(6): 891-900, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239670
5.
Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?
Curr Opin Oncol
; 32(2): 162-169, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876546
6.
Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial.
Blood
; 141(21): 2657-2661, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898087
7.
Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection.
BMC Bioinformatics
; 19(1): 301, 2018 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126372
8.
Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival.
Haematologica
; 108(10): 2794-2798, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021540
9.
Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse.
Br J Haematol
; 166(6): 902-10, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24962064
10.
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia.
Leukemia
; 38(3): 630-639, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272991
11.
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry.
Cytometry B Clin Cytom
; 104(2): 128-140, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289472
12.
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry.
Cytometry B Clin Cytom
; 104(6): 426-439, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766649
13.
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine.
Blood
; 116(15): 2752-8, 2010 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20592250
14.
Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication.
Cancer Drug Resist
; 5(2): 344-367, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35800375
15.
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party.
Hemasphere
; 6(1): e676, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34964040
16.
Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis.
Front Oncol
; 12: 999822, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300090
17.
Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia.
Cancers (Basel)
; 12(5)2020 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32429253
18.
Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Stem Cells
; 26(12): 3059-67, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19096043
19.
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death.
Oncogenesis
; 8(7): 38, 2019 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209198
20.
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML.
Hemasphere
; 7(12): e981, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38026789